Tenderfy

77454 Voluntary ex ante transparency notice

Pasūtītājs
Oslo Universitetssykehus HF (hovedenhet)
Publicēts
2026-11-11
Termiņš
Nav norādīts
Avoti
TED
Vērtība
Nav norādīts

Apraksts

Apraksts ir avota valodā.

77454 RA KRE – Cell processing equipment (Sepax C-Pro) with consumables and service – notice of intention to award a contract without prior publication of a call for competition Oslo University Hospital (OUS) intends to award a contract to Cytiva Europe GmbH, Norwegian Branch (filial Norge), for the purchase of one cell processing instrument (Sepax C-Pro) as a back-up for the existing validated instrument at the Section for Cell Therapy, Radiumhospitalet. The contract also includes a framework agreement for proprietary consumables (single-use kits) and service. The estimated total value is NOK 8.0 million excl. VAT over 10 years, and covers the instrument, consumables and service. Justification for the choice of procedure The contract is awarded without prior publication of a call for competition pursuant to Section 13-4, letter b, no. 2 of the Norwegian Public Procurement Regulations (anskaffelsesforskriften). The full justification is set out in the attached document “Justification for the award of a contract without prior publication of a call for competition”, dated 11 November 2026. Any objections must be submitted in writing to the contact person via Mercell within 10 days after publication of the notice.

CPV: 33000000, 38000000

Dalība

Paziņojumu priekšskatījumi ir bez maksas. Saitēm uz oficiālajiem paziņojumiem un dokumentiem, būvatļaujām un personīgai MCP piekļuvei nepieciešama aktīva maksas dalība.

Lasīt